ABOUT THIS EPISODE
Are you up to speed on the latest updates on molecular-guided therapies in HR-positive/HER2-negative metastatic breast cancer (MBC)? Join us to learn more.
Credit available for this activity expires: 9/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/translating-molecular-insights-practice-hr-positive-her2-2026a1000y0g?ecd=bdc_podcast_libsyn_mscpedu
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
Can CAR T-cell therapies achieve drug-free remission in severe refractory autoimmune diseases?
Credit available for this activity expires: 9/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journey-severe-refractory-autoimmune-rheumatic-2026a1…
Fatigue, unpredictability, and life goals; integrate what patients say they need into how you treat myasthenia gravis (MG).
Credit available for this activity expires: 9/4/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/whole-patient-integrating-lived-e…
Are your epilepsy patients achieving true seizure freedom, or is it time to adjust their therapy?
Credit available for this activity expires: 9/1/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/epilepsy-general-neurology-practice-optimizing-therapeutic-…
Discover how emerging targeted therapies address systemic drivers in MASLD and MASH.
Credit available for this activity expires: 9/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/targeting-metabolic-driver-forward-looking-approach-obesity-2026a1000t0l…
Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
